The rotavirus spike protein VP4 mediates attachment to host cells and subsequent membrane penetration. The VP8 * domain of VP4 forms the spike tips and is proposed to recognize host-cell surface glycans. For sialidase-sensitive rotaviruses such as rhesus (RRV), this recognition involves terminal sialic acids. We show here that the RRV VP8 * 64-224 protein competes with RRV infection of host cells, demonstrating its relevance to infection. In addition, we observe that the amino acids revealed by X-ray crystallography to be in direct contact with the bound sialic acid derivative methyl α-D-N-acetylneuraminide, and that are highly conserved amongst sialidase-sensitive rotaviruses, are residues that are also important in interactions with host-cell carbohydrates. Residues Arg101 and Ser190 of the RRV VP8 * carbohydrate-binding site were mutated to assess their importance for binding to the sialic acid derivative and their competition with RRV infection of host cells. The crystallographic structure of the Arg 101 Ala mutant crystallized in the presence of the sialic acid derivative was determined at 295 K to a resolution of 1.9Å. Our multidisciplinary study using X-ray crystallography, saturation transfer difference nuclear magnetic resonance spectroscopy, isothermal titration calorimetry, and competitive virus infectivity assays to investigate RRV wild-type and mutant VP8 * proteins has provided the first evidence that the carbohydrate-binding cavity in RRV VP8 * is used for host-cell recognition, and this interaction is not only with the sialic acid portion but also with other parts of the glycan structure.
Introduction
Rotaviruses belong to the Reoviridae family of icosahedral, nonenveloped, double-stranded RNA viruses and are recognized as the most important cause of severe gastroenteritis in the young of most mammals, including humans. Rotavirus disease afflicts 100 million young children worldwide leading to 600 000 infant deaths annually (Parashar et al. 2006 ). This high mortality indicates the importance of understanding rotavirus tropism and has driven significant research efforts toward the development of vaccines and chemotherapeutic agents (Angel et al. 2007) .
The surface of the triple-layered rotavirus virion comprises dimeric or possibly trimeric VP4 spikes and calcium-dependent trimers of the coat glycoprotein VP7 (Estes and Kapikian 2007) . During cell entry, the triple-layered particle loses its outer layer, becoming the transcriptionally active double-layered particle. Both VP4 and VP7 have been implicated in initial host-cell interactions, including ganglioside binding (Delorme et al. 2001; Graham et al. 2006; Estes and Kapikian, 2007) . VP4 has specific roles in virus-cell attachment and entry, hemagglutination, neutralization, and virulence (Jayaram et al. 2004; Lopez and Arias 2004; Estes and Kapikian 2007) . During the multistep cell entry process, VP4 is proteolytically cleaved to give an N-terminal hemagglutinin (VP8 * ) and a C-terminal membrane penetration protein (VP5 * ), both of which remain associated within the virion (Dormitzer et al. 2001) . One model of cell entry suggests that the virion initially interacts with a sialic acid-containing receptor prior to additional factors including several integrins and a heat shock protein that are possibly organized within cell membrane lipid microdomains (rafts) (Graham et al. 2003; Jayaram et al. 2004; Lopez and Arias 2004 ). The precise role and requirement of sialic acids for infection is a topic of some debate (Delorme et al. 2001; Ciarlet et al. 2002; Isa et al. 2006) . The receptor specificity of triple-layered particles from several rotavirus strains has been investigated by analyzing their infectivity in cultured cells following pretreatment with sialidases that cleave terminal sialic acid residues (such as Nacetylneuraminic acid) from cell surface glycoconjugates (e.g., GM3) but not subterminal (internal) sialic acid residues such as those found in GM1 (Fukudome et al. 1989; Hikita et al. 2000; Ciarlet et al. 2002) . "Sialidase-sensitive" as opposed to "sialidase-insensitive" thus refers to whether or not interaction with terminal sialic acids occurs during infectivity, rather than an absolute requirement for sialic acids in the binding of rotaviruses to host cells. Sialic acids probably are involved in cell recognition by most, if not all, rotaviruses (Beisner et al. 1998; Guo et al. 1999; Jolly et al. 2000; Delorme et al. 2001; Isa et al. 2006) . The exact mechanisms of cell entry are anticipated to differ between rotaviruses since sialidase-insensitive strains infect polarized epithelial cells from either apical or basolateral membranes, whereas the sialidase-sensitive strains only enter at the apical surface (Ciarlet et al. 2001) .
To investigate the importance of sialic acid recognition, we initiated structural studies on the VP8 * domain from the sialidase-sensitive porcine CRW-8 VP8 * bound to the α-methyl glycoside of N-acetylneuraminic acid (methyl α-D-N-acetylneuraminide (Neu5Acα2Me)) Blanchard et al. 2007 ) and from the sialidase-insensitive Wa rotavirus (Kraschnefski et al. 2005; Blanchard et al. 2007 ). Here, we now report the first room temperature (295 K) X-ray crystallographic structure of the RRV VP8 * 64-224 bound to Neu5Acα2Me, indicating structural flexibility in the VP8 * domain. A part of the shallow cleft that constitutes the sialoside binding-site is formed by the amino acids Ser190 and Arg101 that directly make contact with Neu5Acα2Me. These residues are highly conserved amongst sialidase-sensitive rotaviruses. We have generated two site-directed mutants (Arg 101 Ala, Ser 190 Ala) of these key RRV VP8
* residues in order to assess their importance in binding Neu5Acα2Me and host-cell carbohydrates. Mutant VP8 * binding to Neu5Acα2Me was assessed using saturation transfer difference nuclear magnetic resonance (STD-NMR) spectroscopy and isothermal titration calorimetry (ITC). The X-ray crystallographic structure of the Arg 101 Ala VP8 * crystallized in the presence of Neu5Acα2Me also was determined. Finally, competitive inhibition of RRV infectivity by wild-type (wt) and mutant VP8
* demonstrated the functional relevance of this domain and the biological impact of mutation of these two residues considered key for recognition of host-cell carbohydrates.
Results and discussion

X-ray crystallographic structures of wt and Arg 101 Ala mutant RRV VP8 *
64-224
The structure of wt RRV VP8 * 64-224 in complex with Neu5Acα2Me was determined at 100 K and at 295 K, and refined to 1.55Å and 1.75Å resolution, respectively (Table I) . The structure of the VP8 * Arg 101 Ala mutant in complex with Neu5Acα2Me was determined at 295 K to a resolution of 1.9Å. The rotavirus VP8 * monomer comprises an antiparallel β-sandwich, and in structures of the sialidase-sensitive strains RRV (Dormitzer et al. 2002) and CRW-8 ), Neu5Acα2Me binds in a cleft formed at one edge of the two β-sheets. A comparison of the VP8 * Arg 101 Ala mutant structure with both of our wild-type structures, and that previously reported at 100 K (PDB code 1KQR; Dormitzer et al. 2002) , displays consistency in the overall fold, with a root-mean-square deviation less than 0.22Å (Cα residues Leu65-Leu224). However, in the Gly156-Pro157 region adjacent to the sialoside, our structures reveal a predominant trans proline conformer, whereas cis-trans isomerization was more strongly evident in the 1KQR structure. The Neu5Acα2Me lies within a shallow cleft, one side of which is formed by the β-sheet strand that holds Ser190. The Neu5Acα2Me is anchored to the protein by direct and water-mediated hydrogen bonds ( Figure 1A ). The Arg101 and Ser190 side chains directly hydrogen bond to the ligand's glycerol side chains and carboxylate group, respectively, suggesting that they are important for binding by this sialoside. 
In the VP8
* Arg 101 Ala mutant protein structure, binding to Neu5Acα2Me was maintained ( Figure 1B ). Arginine at this position would make direct hydrogen bonds to the Neu5Acα2Me glycerol side chain, and this residue is highly conserved at position 101 in sialidase-sensitive rotavirus strains. Thus, Arg101 mutation was anticipated to abolish RRV VP8 * binding to Neu5Acα2Me. However, the ligand binds in a manner akin to the wt, apart from the lack of the direct interaction between the ligand glycerol side chain and Ala101. Electron density reveals a well-defined water molecule in the position previously occupied by the Arg101 guanidinium group, which hydrogen bonds to the glycerol side chain of Neu5Acα2Me and must compensate substantially for the loss of the Arg101 side chain (Figure 1B) . The water molecule is stabilized by hydrogen bonds to the Ser190 main chain carbonyl and via another water molecule to the Asp100 carbonyl group. This hydrogen bonding scaffold fixes the position of these waters and appears to have effectively enabled retention of ligand binding to this RRV VP8 * Arg 101 Ala mutant.
Effect of mutation of VP8
* Arg 101 and Ser 190 on sialic acid recognition Binding of Neu5Acα2Me to wt RRV VP8 * was detected using STD-NMR spectroscopy (Haselhorst et al. 2007) . With this technique (Mayer and Mayer 1999) , an interaction was not observed for the Arg 101 Ala and Ser 190 Ala VP8 * proteins, indicating that mutations have either abolished interaction, or substantially reduced binding to Neu5Acα2Me to render it M J Kraschnefski et al. 
undetectable (see supplementary Figure) . Using ITC, a K d of 0.33 mM (SD 0.09 mM) (with stoichiometry (n) set to 1 the K d is 0.30 mM) for wt RRV and Neu5Acα2Me was determined ( Figure 2 * did not form crystals under the wt crystallization conditions wherein the bound ligand would be engaged in crystal packing, providing an additional indication that it does not bind appreciably to Neu5Acα2Me monosaccharide. Importantly, in our crystallographic structure of the RRV VP8 * Arg 101 Ala, which did bind Neu5Acα2Me, the ligand exhibits the same orientation as with the wt protein, with the proviso that a water molecule assists in anchoring the ligand. These data suggest that this mutant VP8 * retains some capacity to bind sialic acids. Lectins generally demonstrate only weak interactions with host-cell carbohydrate receptors and are anticipated to have even lower affinities for simple monosaccharides. The STD-NMR, ITC, and cocrystallization experiments would have been performed at the limits of detection for the low level of the interaction between Neu5Acα2Me and the mutant VP8 * . It remains to be proven, if Neu5Acα2Me binding to Ser 190 Ala VP8 * has been reduced, as for Arg 101 Ala VP8 * , or abolished. In any case, it is clear that mutation of these amino acids has decreased the VP8 * capacity to interact with the sialic acid derivative. These amino acids directly interact with the sialoside in VP8 * of RRV, as in another sialidase-sensitive rotavirus, CRW-8 . These data support the importance of the cleft containing Arg101 and Ser190 in recognition of sialic acids.
Competition by wt and mutant RRV VP8 *
64-224 with RRV infectivity
To assess whether these findings translate to the RRV VP8 * interaction with cell surface carbohydrates, the extent of competition by wt and mutant RRV VP8 * 64-224 with RRV infection was investigated using permissive MA104 cells (Figure 3 ). All VP8 * 64-224 proteins significantly reduced RRV infectivity (P < 0.001; Figure 3A ). This demonstrates that wt RRV VP8 * 64-224 recognizes host cells similarly to virion VP8 * . The K d values of the VP8 * interaction with Neu5Acα2Me cannot be quantitatively related to the degree of VP8
* competition with RRV, as multivalent interactions will occur between VP8 * and cell surface glycans. Supporting this, sialic acid presented on sialylphospholipid vesicles has been shown to inhibit rotavirus infection with 1000-fold greater potency than soluble sialic acid (Koketsu et al. 1997) . However, our results do clearly demonstrate a trend of competitive ability. The wt VP8 * was most competitive, reducing RRV infectivity by 37% at 50 µg/mL and 58% at 150 µg/mL (P <0.001). less efficiently, behaving comparably to wt at 50 µg/mL (32% infectivity reduction; P < 0.001) but reducing infectivity less than wt at 150 µg/mL (40%; P < 0.05 cf. wt). The Arg 101 Ala VP8 * showed no competition at 50 µg/mL (P > 0.05) and reduced infectivity by 21% at 150 µg/mL (P < 0.001). This was significantly less than wt competition (P < 0.001; Figure 3A) . However, at 300 µg/mL both mutant proteins reduced RRV infectivity to a similar extent (44-48%), which was significantly less than the competition by wt VP8 * at this concentration (56%; P < 0.037).
Sialidase treatment reduced RRV infectivity in MA104 cells to 44 % of untreated levels ( Figure 3B ). The VP5 * subunit of VP4 also competes with RRV infectivity, which probably accounts for much of the residual RRV infectivity in sialidasetreated cells. These data demonstrate a clear interaction by rhesus rotavirus with terminally located sialic acids on cellular carbohydrates. After sialidase treatment, wt VP8 * was less competitive than in untreated cells, reducing RRV infection by 23% at 50 µg/mL and 37% at 150 µg/mL (P < 0.001; Figure 3B ). Thus, competing wt VP8 * preferentially interacts with terminal sialic acids. Neither mutant VP8
* competed at 50 µg/mL after sialidase treatment of cells (P > 0.05; Figure 3B ). At 150 µg/ mL, the wt and Arg 101 Ala VP8
* reduced infectivity similarly (by 36% and 33%, respectively; P < 0.001), whereas the Ser 190 Ala mutant VP8
* was noncompetitive (P > 0.05; Figure 3B ). Similar results were obtained using VP8 * at 300 µg/ mL. This trend of slightly reduced competition by the Arg 101 Ala VP8
* is consistent with our STD-NMR and ITC findings, show- ing that this VP8 * had a reduced ability to bind Neu5Acα2Me. It is proposed that the Arg101 mutant retains a reduced capacity to bind to the remaining glycan structure. Intriguingly, the Ser 190 Ala mutation completely abrogated VP8 * competition with RRV infectivity after sialidase treatment ( Figure 3B ). Thus, Ser 190 Ala mutation reduced VP8 * binding to cells but abolished it only after terminal sialic acid removal. The MA104 cell surface contains GM1a (31%), GM3 (27%), and lactosylceramide (LacCer). After sialidase (Arthrobacter ureafaciens) treatment, GM3 levels decreased and LacCer correspondingly increased due to the enzymatic removal of GM3 terminal sialic acids (Guo et al. 1999) . Competition of wt VP8 * with infectivity after sialidase treatment, thus, can be explained by VP8 * recognition of the remaining uncapped glycan structure.
The lack of infectivity competition by Ser 190 Ala VP8 * at any concentration shows that this VP8 * cannot recognize the glycan structure remaining after sialidase treatment and indicates the absolute requirement for serine at position 190 for successful recognition of this remaining glycan. Our crystallographic structures in conjunction with NMR results (Dormitzer et al. 2002) support the concept that ligand binding induces stability, particularly in the region of the Ser190 backbone. Flexibility in this region prior to the ligand interaction is important as it suggests that some interaction between the serine and part of an incoming ligand is required to sufficiently stabilize that region for successful binding. Ser190 interacts with the carboxylate group of sialic acids associated with glycoconjugates. Interestingly, the VP8 * Ser 190 Ala still showed some infectivity competition in untreated cells ( Figure 3A ). Mutation to alanine would leave only the possibility of the backbone amide for hydrogen bonding to sialic acids. Whilst speculative, it is feasible that the sialic acid portion of the ligand could be sufficiently held by other components of the binding site, including Arg101, allowing retention of the now Ala190 backbone amide interaction with the carboxylate group. This ligand anchoring would be anticipated to produce stabilization around residue 190, which could be transmitted further along the peptide chain segment [191] [192] . Following terminal sialic acid removal, we suggest that the backbone of residue 190 would no longer interact with the remaining glycan. This hypothesis is based on the knowledge of the direction and orientation of the OMe aglycon of the bound Neu5Acα2Me ( Figure 1A) . It is expected from this that the remaining uncapped glycan structure would run along the groove bordered by peptide segments 190-193 and 99-101. As such, the exposed glycose residue of the asialoglycan would be too distant from the backbone amide of 190 to make any contact. As wt VP8 * and Arg 101 Ala still compete with infectivity after sialidase treatment ( Figure 3B ), they appear able to interact with glycan structures devoid of terminal sialic acids. The Ser190 side chain may redirect toward this groove and interact with part of the asialoglycan, for example, the uncapped galactose, enabling sufficient anchoring to stabilize the protein structure around residue 190.
Overall, our findings support the contention that the Neu5Acα2Me binding site determined by X-ray crystallography corresponds to the site of the interaction with terminal sialic acids on cell-surface glycans. A key finding is that mutation of amino acids Arg101 and Ser190 in that site reduced the capacity of RRV VP8 * both to bind Neu5Acα2Me and to compete with infectious RRV for the interaction with MA104 cell-surface glycans. Both wt and mutant VP8 * proteins inhibited RRV infectivity prior to sialidase treatment. Apart from the Ser 190 Ala mutant, the VP8 * proteins also inhibited RRV infectivity after terminal sialic acid removal. We propose a structure-based rationalization of our competitive assay data in which the VP8 * sialic acid derivative binding site (formed at the interface of the β-sheets) interacts only with terminal sialic acids, engaging with amino acids including Ser190 and Arg101, and that this cleft has additional capacity to recognize the aglycon portion of cell-surface glycans. Our investigation demonstrates VP8 * interactions with both the sialic acid portion and the aglycon and provides the first demonstration that mutation at this carbohydrate-recognition cleft affects the ability of VP8 * to compete with rotavirus for the interaction with host-cell carbohydrates.
Material and methods
Cloning, expression, and purification of wild-type and site-directed mutants of RRV VP8 *
64-224
RRV VP8 * 64-224 was cloned, expressed, and purified as previously reported (Haselhorst et al. 2007 ). Briefly, a construct encoding residues Val64-Leu224 of RRV VP4 (amino acid sequence as per accession number AY033150, Entrez Database) was fused to the C-terminus of a glutathione-S-transferase tag and over-expressed in Escherichia coli. Wt and mutant proteins were purified by glutathione-sepharose affinity chromatography. Constructs with the single point mutations Arg 101 Ala and Ser 190 Ala were created using the QuickChange R site-direected mutagenesis kit (Stratagene, La Jolla, CA, USA) with forward primers of CT AAT AAT ACA GAC GCG TGG CTA GCT ACA ATT TAA GTT GAG CCA AAC G (Arg 101 Ala mutant) and GTG ACC ACT AAG TAT TAC GCA ACT ACA AAT TAT GAT TCA GTA AAC ATG AC (Ser 190 Ala mutant) and reverse complementary primers (mutated bases in bold face, shaded segments indicate the restriction enzyme digest regions in which silent mutations were made). The integrity of the mutated VP8 * gene fragment was confirmed by DNA sequencing and subsequently cloned into the pGEX-4T-1 (Amersham-Pharmacia Biotech, Piscataway, NJ, USA) expression vector using the BamHI and EcoRI restriction sites creating an in-frame fusion downstream of GST. The VP8 * protein was concentrated and assessed for purity via sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). Samples were analyzed by dynamic light scattering (CoolBatch + 90T instrument (Precision Detectors, Bellingham, MA, USA) at 293K, protein concentration of 20 mg/mL, 10 repeats) and indicated a monomodal distribution representing a single protein species with a hydrodynamic radius (Rh) of ∼1.54 nm. The polydispersity of the purified RRV VP8
* 64-224 peak is 21.9% and is within the range (15-30%) indicative of good homogeneity.
Isothermal titration calorimetry
The RRV VP8
* protein was diluted to 0.5 mM in the TNE buffer. Ligands were solubilized at 30 mM in the same buffer. For the RRV VP8 * Arg 101 Ala, an additional experiment was undertaken at higher concentration of 1 mM protein with 60 mM Neu5Acα2Me concentration. Solutions were degassed using ThermoVac (MicroCal Americas, Northampton, MA, USA), pH checked and titrated in a VT-ITC MicroCalorimeter (MicroCal, Inc.) using 3 µL injections applied 4 min apart. Data for the blank sample were obtained by titration of the ligand into a buffer solution without protein. Titration data were collected at 4
• C, replicated four times. Binding isotherms were fitted by nonlinear regression using a single-site model and Origin software (MicroCal). The stoichiometry of the interaction (N), equilibrium association constant (K a ), and change in enthalpy ( H) were floated during the fitting of the data until the χ2 factor remained constant with values for the blank subtracted. Equilibrium dissociation constant (K d ) was then calculated as a reciprocal of K a . It should be noted that the K d values obtained for individual titrations were comparable to the protein concentration used in the experiments (0.5 mM); therefore, the c-value (c = [P]/K d ) obtained was less than 1. Under such low c-value conditions, both G and H can be measured with confidence provided binding saturation of at least 80% is achieved at the end of the titration and the stoichiometry of binding (n) is known (Turnbull and Danaras 2003) . In our experiments, ligand (Neu5Acα2Me) was added in excess (3×) and is sufficient for the required 80% binding saturation at the end of the experiment. In addition, to obtain more accurate the G and H values, the stoichiometry (n) was either fixed or floated and resulting K d values were then compared. This was possible as the stoichiometry of binding was determined in several previous studies using different methods, including X-ray crystallography and NMR (e.g. Dormitzer et al 2002; Blanchard et al. 2007 ). The K d values obtained when n was either fixed or alternatively floated were found to be in good agreement (0.3 mM vs. 0.33 mM, respectively) giving confidence in the values associated with the affinity of this ligand.
Saturation transfer difference nuclear magnetic resonance STD NMR spectra were acquired on a Bruker 600 MHz Avance spectrometer at 288 K using a conventional 1 H/ 13 C/ 15 N gradient cryoprobe system. Deuterium oxide (99.9%, deuterium; Novachem Pty, Australia). Tris (hydroxymethyl) methylamine (D 11 , 98%) NMR samples were prepared by dissolving VP8 * proteins (0.5 mg) with ligand, giving a protein:ligand ratio of 1:100 in 600 µL of NMR buffer (20 mM phosphate buffer, pH 7.1, 10 mM NaCl). One-dimensional STD was performed on the Neu5Acα2Me ligand as described (Haselhorst et al., 2007) . Briefly, protein was saturated at 7.13 ppm in the aromatic/amide region of the spectrum and off-resonance at 33 ppm. A 100 µs delay between each soft pulse was applied, giving a total saturation time of 2 s. Data were obtained with an interspersed acquisition of pseudo-two-dimensional on-resonance and offresonance spectra. On-and off-resonance spectra were processed separately to obtain the final STD NMR spectrum by subtracting individual on-and off-resonance spectra.
Assay for VP8 * competition with RRV infection
This assay was adapted from rotavirus infectivity assays described previously (Graham et al. 2003 (Graham et al. , 2004 . In brief, confluent MA104 cell monolayers (approx. 4×10 4 cells) were either untreated or treated with sialidase from Vibrio cholerae (Sigma) at 0.52 U/mL in a serum-free cell culture medium, or medium alone, for 1 h at 37
• C. After cooling to 4
• C and removal of sialidase, cells were treated with VP8 * (1-300 µg/mL), bovine serum albumin (Sigma; 300 µg/mL) or medium at 4
• C for 30 min. RRV was produced and trypsin-activated. Activated RRV was cooled and allowed to bind to cells at a multiplicity of infection of 0.02 (MA104 cells) for 1 h at 4
• C. Following inoculum removal and washing, cells were incubated for 16 h at 37
• C in 95% (vol/vol) air with 5% (vol/vol) CO2. Virus titres in acetone-fixed cell monolayers were determined by indirect immunofluorescence. Differences in titres were analyzed for statistical significance by one-way analysis of variance. Significance was set at P < 0.05.
Protein crystallization, X-ray diffraction data collection, and structure determination Using crystallization conditions based upon those reported for RRV VP8 * 64-224 (Dormitzer et al., 2002) , crystals of wt RRV VP8 * 64-224 in complex with methyl α-D-N-acetylneuraminide (Neu5Acα2Me) were produced. Specifically, a solution containing 40 mg/mL RRV VP8 * , 122 mM Neu5Acα2Me, 5.6 mM Tris, pH 8.0, 14 mM NaPO 4 , pH 7.0, 35 mM NaCl, 0.3 mM EDTA, pH 8.0, 0.1 mM benzamidine and 0.02% w/v NaN 3 was mixed with an equal amount of reservoir solution containing 1.7 M (NH 4 ) 2 SO 4 , 2.4% v/v PEG 400 and 0.1 M PIPES, pH 6.5. Crystals of typical dimensions 1.2 × 0.9 × 0.5 mm grew in 3-7 days at 303 K. Identical conditions, except with an increased concentration (to 180 mM) of Neu5Acα2Me, were used to crystallize the RRV VP8 * Arg 101 Ala mutant, as well as in unproductive trials of the Ser 190 Ala mutant VP8 * protein. The X-ray crystal structure of wt RRV VP8 * 64-224 in complex with Neu5Acα2Me was determined at 100 K and at 295 K, to 1.55Å and 1.75Å resolution, respectively. Prior to 100 K data collection, crystals were briefly soaked in a solution of 20 mM Neu5Acα2Me, 1.8 M (NH 4 ) 2 SO 4 , 2.6% v/v PEG 400, 0.1 M PIPES, pH 6.5, 0.1 mM benzamidine, 0.02% w/v NaN 3 and 20% v/v glycerol and frozen by immersion in liquid nitrogen. X-ray diffraction data were collected from one crystal of the RRV VP8 * Neu5Acα2Me complex to 1.55Å resolution (FIP-BM30A station, ESRF) at 100 K, with λ = 0.9794Å using a MAR CCD detector. Data were integrated using MOS-FLM (Leslie 1992) and scaled with SCALA (CCP4 1994). The crystal belongs to spacegroup P4 1 2 1 2, unit cell parameters a = b = 47.89, c = 129.93Å, one protein molecule per asymmetric unit, and a calculated solvent content of 39.6 %. X-ray diffraction data were collected at 295 K for both the wt RRV VP8 * (1.75Å) and also the Arg 101 Ala mutant (1.9Å) with λ = 1.5418 A on a ProteumR (Bruker AXS, Madison) diffractometer with a MacScience M06XCE rotating anode generator equipped with a SMART6000 CCD detector. Data were integrated using SAINT (v.1.0: Bruker AXS, Madison, WI), scaled with PROSCALE (v.7.10: Bruker AXS, Madison, WI). Data statistics is shown in Table I . The RRV VP8 * (PDB code 1KQR (Dormitzer et al. 2002) atomic structure with side chains of amino acids in the binding pocket truncated (to avoid potential model bias) was used as a starting refinement model (REFMAC) (Murshudov et al. 1997 ) of all the structures. Electron density maps calculated with coefficients 2|F o | − |F c | α c and |F o | − |F c | α c , where |F o | and |F c | are observed and calculated structure factor amplitudes, and calculated model phases enabled structure rebuilding (COOT; Emsley and Cowtan 2004) . Structural stereochemical quality was assessed using PROCHECK (Laskowski et al. 1993) and SFCHECK (Vagin et al. 1999) . The X-ray crystal structure of wt RRV VP8 * 64-224 in complex with Neu5Acα2Me at 100 K refined to 1.55Å with a final R factor of 17.2% and R free of 20.0%, with that 295 K to 1.75Å with an R factor of 16.3% and R free of 18.8%, respectively (Table I) . Our RRV VP8
* structures comprise residues Val64-Leu224, one Neu5Acα2Me molecule, 1 sulfate ion, and 235 (100 K structure) and 133 (295 K structure) ordered water molecules. Additionally, in the 100 K structure there are one glycerol molecule and indication of a partially occupied Na + . Identification of partial occupancy by the ion was based on a number of observations. A low temperature factor (Bfactor) of 5.3Å 2 was exhibited when refined as a water molecule, with that of 8.6Å
2 when refined as a Na + . In addition, there is potential for octahedral coordination via side-chains of Lys187A, Asn142, Tyr165, and Thr176 and backbone carbonyl groups of Tyr177 and Gly156, and bond lengths (2.3Å to 2.77Å) appropriate for NA + coordination. We have modeled a water molecule (W1, PDB code 2P3K) in the structure, however we believe that an alternative interpretation is that of a partially occupied Na + being present only when conformer B is adopted. The RRV VP8 * Arg 101 Ala mutant in complex with Neu5Acα2Me comprising residues V64-L224 (with the Arg 101 Ala mutation), one Neu5Acα2Me, one sulfate, and 134 ordered water molecules was refined to 1.9Å resolution with an R factor of 16.1% and R free of 20.6% (Table I) . Unless otherwise stated, the figures were created using PyMOL (http://www.pymol.org).
Protein Data Bank accession codes
The X-ray crystallographic structure coordinates have been deposited in the Protein Data Bank (http://www.rscb.org/pdb),
